Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug

This week Lilly (LLY – Free Report) and AstraZeneca (AZN – Free Report) released their third-quarter 2018 results. Pfizer (PFE – Free Report) gained FDA approval for a new cancer medicine, its third c…